Atlas Trials

Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT01562405 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01562405
Sponsor
Massachusetts General Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-05-01
Primary completion
2026-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.